Compare BIO & BSAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | BSAC |
|---|---|---|
| Founded | 1952 | 1977 |
| Country | United States | Chile |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Commercial Banks |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9B | 17.0B |
| IPO Year | N/A | 2002 |
| Metric | BIO | BSAC |
|---|---|---|
| Price | $245.79 | $30.72 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | ★ $339.75 | $33.00 |
| AVG Volume (30 Days) | 329.8K | ★ 440.5K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.51% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.74 | $37.15 |
| Revenue Next Year | $3.20 | $7.52 |
| P/E Ratio | ★ $9.72 | $14.40 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $211.43 | $22.77 |
| 52 Week High | $343.12 | $37.72 |
| Indicator | BIO | BSAC |
|---|---|---|
| Relative Strength Index (RSI) | 34.33 | 41.59 |
| Support Level | N/A | $29.41 |
| Resistance Level | $311.53 | $33.36 |
| Average True Range (ATR) | 9.57 | 0.96 |
| MACD | -3.28 | -0.19 |
| Stochastic Oscillator | 16.91 | 31.64 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Founded in 1978, Banco Santander Chile is part of Santander Group and majority-controlled by Santander Spain. It is the largest bank in Chile by loans and the second largest by deposits. The bank generates most of its net interest income (roughly 65% of total revenue) from its mortgages, unsecured consumer credit lines, and commercial loans. Banco Santander's commercial loan business is more focused on small- to medium-size companies, with firms generating more than CLP 10,000 million in revenue only making up around 5% of outstanding loans. Outside of lending, Banco Santander is the largest card issuer in the country with around 25% of the market and benefits from a long-term strategic partnership with the largest airline in the country, LATAM.